Union Chimique Belge
Brussels · Founded 1928
About Union Chimique Belge
UCB focuses on research and development of medications centered on epilepsy, parkinson's disease, and crohn's disease. Their research and development activities in neurology, immunology, and other areas.
Company Facts
- Founded: 1928
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 5,001 – 10,000
- Estimated revenue: $1M – $10M
- Total funding: $201.8M
- Funding stage: IPO
- Last round: Post-IPO Equity (May 2022)
- Ticker: ebr:UCB
- Website: ucb.com
- Phone: +32 2 559 99 99
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/union-chimique-belge-10329 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.